Comparing C3a and C5a serum concentrations before and under ERT, we found significantly increased C3a (Figure 3D) and C5a (Figure 3H) concentrations in ADA-positive patients, whereas anaphylatoxin levels were heterogenous in ADA-negative FD patients after ERT. This evidence concerns the gene C3 and Fabry disease.